Department of Cardiology, AHEPA University Hospital, Thessaloniki, Greece.
Department of Cardiology, General Hospital "George Papanikolaou", Thessaloniki, Greece.
Int J Cardiol. 2017 Oct 15;245:109-113. doi: 10.1016/j.ijcard.2017.07.024. Epub 2017 Jul 13.
The majority of patients with congenital heart disease (CHD), nowadays, survives into adulthood and is faced with long-term complications. We aimed to study the basic demographic and clinical characteristics of adult patients with congenital heart disease (ACHD) in Greece.
A registry named CHALLENGE (Adult Congenital Heart Disease Registry. A registry from Hellenic Cardiology Society) was initiated in January 2012. Patients with structural CHD older than 16years old were enrolled by 16 specialized centers nationwide.
Out of a population of 2115 patients with ACHD, who have been registered, (mean age 38years (SD 16), 52% women), 47% were classified as suffering from mild, 37% from moderate and 15% from severe ACHD. Atrial septal defect (ASD) was the most prevalent diagnosis (33%). The vast majority of ACHD patients (92%) was asymptomatic or mildly symptomatic (NYHA class I/II). The most symptomatic patients were suffering from an ASD, most often the elderly or those under targeted therapy for pulmonary arterial hypertension. Elderly patients (>60years old) accounted for 12% of the ACHD population. Half of patients had undergone at least one open-heart surgery, while 39% were under cardiac medications (15% under antiarrhythmic drugs, 16% under anticoagulants, 16% under medications for heart failure and 4% under targeted therapy for pulmonary arterial hypertension).
ACHD patients are an emerging patient population and national prospective registries such as CHALLENGE are of unique importance in order to identify the ongoing needs of these patients and match them with the appropriate resource allocation.
如今,大多数患有先天性心脏病 (CHD) 的患者都能存活到成年,并面临长期并发症。我们旨在研究希腊成人先天性心脏病 (ACHD) 患者的基本人口统计学和临床特征。
2012 年 1 月启动了一个名为 CHALLENGE(成人先天性心脏病登记处。来自希腊心脏病学会的登记处)的登记处。全国 16 个专门中心招募了年龄超过 16 岁的结构性 CHD 患者。
在已登记的 2115 名 ACHD 患者中(平均年龄 38 岁(标准差 16),52%为女性),47%为轻度,37%为中度,15%为重度 ACHD。房间隔缺损 (ASD) 是最常见的诊断(33%)。绝大多数 ACHD 患者(92%)无症状或仅有轻度症状(NYHA Ⅰ/Ⅱ级)。症状最明显的患者患有 ASD,多为老年人或正在接受肺动脉高压靶向治疗的患者。年龄较大的患者(>60 岁)占 ACHD 人群的 12%。一半的患者至少接受过一次心脏直视手术,而 39%的患者正在服用心脏药物(15%服用抗心律失常药物,16%服用抗凝药物,16%服用心力衰竭药物,4%服用肺动脉高压靶向治疗药物)。
ACHD 患者是一个新兴的患者群体,像 CHALLENGE 这样的国家前瞻性登记处具有独特的重要性,以便确定这些患者的持续需求,并将其与适当的资源分配相匹配。